Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bio Green Med Solution (BGMS) Invested Capital (2016 - 2025)

Historic Invested Capital for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to $7.1 million.

  • Bio Green Med Solution's Invested Capital rose 83154.64% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 83154.64%. This contributed to the annual value of -$2.2 million for FY2024, which is 45815.49% down from last year.
  • As of Q3 2025, Bio Green Med Solution's Invested Capital stood at $7.1 million, which was up 83154.64% from $3.6 million recorded in Q2 2025.
  • Bio Green Med Solution's Invested Capital's 5-year high stood at $48.0 million during Q1 2021, with a 5-year trough of -$2.2 million in Q1 2024.
  • For the 5-year period, Bio Green Med Solution's Invested Capital averaged around $16.0 million, with its median value being $7.1 million (2025).
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 45815.49% in 2024, then skyrocketed by 83154.64% in 2025.
  • Over the past 5 years, Bio Green Med Solution's Invested Capital (Quarter) stood at $37.7 million in 2021, then tumbled by 57.71% to $15.9 million in 2022, then plummeted by 96.19% to $607000.0 in 2023, then tumbled by 458.15% to -$2.2 million in 2024, then soared by 426.4% to $7.1 million in 2025.
  • Its last three reported values are $7.1 million in Q3 2025, $3.6 million for Q2 2025, and $3.1 million during Q1 2025.